Columbia Research Enhanced Core ETF

RECS · ETF

$45.30−$0.23 (−0.51%)TodayMarket closed ·
Prev close $45.53

About RECS

RECS was created on 2019-09-25 by Columbia. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6241.29m in AUM and 356 holdings. RECS tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting.

Issuer
Columbia
Tracks
Beta Advantage Research Enhanced US Equity Index
Expense ratio
0.15%
Assets under management
$6.25B
Inception
Sep 25, 2019
Asset class
Equity

RECS key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
572.85K
Volume
344.39K
Open price
$45.30
High today
$45.44
Low today
$45.20
52 Week high
$46.03
52 Week low
$37.79

Columbia Research Enhanced Core ETF (RECS) at a glance

Columbia Research Enhanced Core ETF (RECS) last traded at $45.30, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $45.20 and $45.44. The current price is 0.2% above the day's low and 0.3% below its high.

Volume so far is 344.39K shares, below the average of 572.85K shares a day.

Over the past year Columbia Research Enhanced Core ETF has ranged from $37.79 to $46.03, and now sits 91% of the way up that range.

RECS news

  • Press releaseBusiness Wire

    Columbia Threadneedle Investments Launches Six New ETFs Across Equity and Fixed Income

  • Press releaseBusiness Wire

    Columbia Research Enhanced Core ETF (RECS) Celebrates Five-Year Anniversary, $1B AUM Milestone

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.